tiprankstipranks
Editas Medicine Inc (EDIT)
NASDAQ:EDIT

Compare Editas Medicine (EDIT) vs. Competitors

3,556 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Editas Medicine
$2.76
$270.13M
-1.14
181.63%
3 Buy
3 Hold
1 Sell
Moderate Buy
Cellectis SA
$3.55
$260.49M
-7.16
191.46%
1 Buy
1 Hold
0 Sell
Moderate Buy
Foghorn Therapeutics
$4.89
$287.04M
-4.58
52.34%
7 Buy
0 Hold
0 Sell
Strong Buy
Elicio Therapeutics
$10.13
$186.35M
-3.95
95.18%
3 Buy
0 Hold
0 Sell
Strong Buy
Vor Biopharma
$15.74
$769.10M
0.02
43.14%
5 Buy
1 Hold
0 Sell
Strong Buy
Caribou Biosciences
$1.95
$188.44M
-1.42
146.84%
8 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
EDIT
Editas Medicine
2.76
1.65
148.65%
CLLS
Cellectis SA
3.55
2.32
188.62%
FHTX
Foghorn Therapeutics
4.89
1.66
51.39%
ELTX
Elicio Therapeutics
10.13
5.06
99.80%
VOR
Vor Biopharma
15.75
3.27
26.26%
CRBU
Caribou Biosciences
1.95
1.09
126.74%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts